Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2011 by Xiamen University.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Xiamen Innovax Biotech Co., Ltd
Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd
Information provided by:
Xiamen University
ClinicalTrials.gov Identifier:
NCT01356823
First received: May 13, 2011
Last updated: May 17, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2011
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)